Duration of Androgen Suppression in the Treatment of Prostate Cancer
Authors:
- Michel BollaMBMichel Bolla
- Theodorus M. de ReijkeTRTheodorus M. de Reijke
- Geertjan Van TienhovenGTGeertjan Van Tienhoven
- Alphonsus C.M. Van Den BerghABAlphonsus C.M. Van Den Bergh
- Jorg OddensJOJorg Oddens
- Philip M.P. PoortmansPPPhilip M.P. Poortmans
- Eliahu GezEGEliahu Gez
- Paul KilPKPaul Kil
- Atif AkdasAAAtif Akdas
- Guy SoeteGSGuy Soete
- Oleg KariakineOKOleg Kariakine
- Elsbietha M. van der Steen-BanasikESElsbietha M. van der Steen-Banasik
Top Cited Papers
- 11 June 2009
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 360 (24) , 2516-2527
Abstract
The combination of radiotherapy plus long-term medical suppression of androgens (≥2 years) improves overall survival in patients with locally advanced prostate cancer. We compared the use of radiotherapy plus short-term androgen suppression with the use of radiotherapy plus long-term androgen suppression in the treatment of locally advanced prostate cancer.Keywords
This publication has 26 references indexed in Scilit:
- Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate CancerJournal of Clinical Oncology, 2008
- Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610Journal of Clinical Oncology, 2008
- Toward the Optimal Use of Androgen Suppression Therapy in the Radiotherapeutic Management of Prostate CancerJournal of Clinical Oncology, 2007
- Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate CancerJournal of Clinical Oncology, 2006
- Metabolic Syndrome in Men With Prostate Cancer Undergoing Long-Term Androgen-Deprivation TherapyJournal of Clinical Oncology, 2006
- Risk of Fracture after Androgen Deprivation for Prostate CancerNew England Journal of Medicine, 2005
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997
- Checking the Cox model with cumulative sums of martingale-based residualsBiometrika, 1993
- Group sequential designs using a family of type I error probability spending functionsStatistics in Medicine, 1990
- Tables of the number of patients required in clinical trials using the logrank testStatistics in Medicine, 1982